Randomized Placebo-controlled Trial Of An Isoflavone Supplement And Menopausal Symptoms In Women

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 43
Sex Female
Age Range 45-64
Body Types Overweight
Notes for this study:
Supplementation of 40mg Promensil daily over the course of three months was noted to reduce hot flashes relative to placebo when measured at four weeks, but over the course of the 12 week study there were no significant differences in overall menopausal symptoms (Greene Climacteric Scale) or hot flash occurrence.
Funding issues for this study:
Study was Financially Supported by producers of the supplement; Novagen

Full details on all 6 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.